| Primary |
| Back Pain |
17.6% |
| Pain |
15.2% |
| Arthralgia |
8.4% |
| Pyrexia |
7.3% |
| Hypertension |
7.0% |
| Osteoarthritis |
6.9% |
| Rheumatoid Arthritis |
6.9% |
| Arthritis |
4.5% |
| Musculoskeletal Pain |
3.0% |
| Sciatica |
2.9% |
| Pain In Extremity |
2.5% |
| Nasopharyngitis |
2.5% |
| Analgesic Therapy |
2.4% |
| Headache |
2.2% |
| Antipyresis |
1.9% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis |
1.9% |
| Neck Pain |
1.8% |
| Insomnia |
1.6% |
| Migraine |
1.5% |
|
| Vomiting |
12.4% |
| White Blood Cell Count Increased |
10.0% |
| Wrong Technique In Drug Usage Process |
8.8% |
| Shock |
7.8% |
| Off Label Use |
5.1% |
| Rhabdomyolysis |
4.8% |
| Renal Failure Acute |
4.7% |
| Drug Administered At Inappropriate Site |
4.6% |
| Pyrexia |
4.5% |
| Weight Decreased |
4.5% |
| Urticaria |
4.2% |
| Tremor |
3.7% |
| Loss Of Consciousness |
3.6% |
| Therapeutic Response Unexpected |
3.6% |
| Pain |
3.2% |
| Toxic Epidermal Necrolysis |
3.1% |
| Rectal Haemorrhage |
3.0% |
| Surgery |
3.0% |
| Pruritus |
2.9% |
| Renal Failure |
2.8% |
|
| Secondary |
| Rheumatoid Arthritis |
16.6% |
| Product Used For Unknown Indication |
12.2% |
| Drug Use For Unknown Indication |
8.8% |
| Hypertension |
8.4% |
| Pain |
8.0% |
| Back Pain |
6.2% |
| Pyrexia |
5.0% |
| Arthralgia |
3.5% |
| Constipation |
3.5% |
| Osteoarthritis |
3.3% |
| Infection |
3.1% |
| Osteoporosis |
3.1% |
| Prophylaxis |
2.9% |
| Insomnia |
2.7% |
| Gastritis |
2.5% |
| Wound Complication |
2.2% |
| Cerebral Infarction |
2.1% |
| Arthritis |
2.1% |
| Convulsion Prophylaxis |
2.0% |
| Gastric Ulcer |
1.8% |
|
| Vomiting |
12.6% |
| Renal Failure Acute |
10.8% |
| Stevens-johnson Syndrome |
8.3% |
| Toxic Epidermal Necrolysis |
7.9% |
| White Blood Cell Count Increased |
6.2% |
| Wrong Technique In Drug Usage Process |
5.2% |
| Sepsis |
4.6% |
| Renal Failure |
4.3% |
| Renal Impairment |
4.2% |
| Gastric Ulcer |
3.9% |
| Pyrexia |
3.9% |
| Rash |
3.7% |
| Weight Decreased |
3.4% |
| Somnolence |
3.3% |
| Urticaria |
3.3% |
| Loss Of Consciousness |
3.0% |
| Nausea |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Drug Ineffective |
2.8% |
| Interstitial Lung Disease |
2.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
25.5% |
| Product Used For Unknown Indication |
17.2% |
| Drug Use For Unknown Indication |
11.6% |
| Pain |
7.5% |
| Hypertension |
6.5% |
| Prophylaxis |
6.5% |
| Osteoporosis |
2.7% |
| Constipation |
2.6% |
| Cancer Pain |
2.5% |
| Insomnia |
2.4% |
| Hepatitis C |
2.0% |
| Depression |
1.9% |
| Back Pain |
1.8% |
| Diabetes Mellitus |
1.7% |
| Gastritis |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Arthralgia |
1.2% |
| Arthritis |
1.1% |
| Chronic Hepatitis C |
1.1% |
|
| Vomiting |
10.3% |
| Pyrexia |
7.4% |
| White Blood Cell Count Decreased |
7.2% |
| Pneumonia |
6.0% |
| Sepsis |
5.9% |
| Nausea |
5.5% |
| Weight Decreased |
5.3% |
| Rash |
5.3% |
| Interstitial Lung Disease |
4.5% |
| Urinary Tract Infection |
4.3% |
| Urticaria |
4.3% |
| Renal Failure Acute |
4.2% |
| Rheumatoid Arthritis |
4.2% |
| Renal Impairment |
4.0% |
| White Blood Cell Count Increased |
3.9% |
| Somnolence |
3.8% |
| Weight Increased |
3.8% |
| Thrombocytopenia |
3.5% |
| Pulmonary Embolism |
3.4% |
| Tremor |
3.4% |
|
| Interacting |
| Hypertension |
13.9% |
| Drug Use For Unknown Indication |
12.0% |
| Pain |
10.1% |
| Atrial Fibrillation |
8.7% |
| Back Pain |
6.7% |
| Bone Pain |
5.8% |
| Osteoporosis |
4.8% |
| Migraine |
4.3% |
| Arthralgia |
3.8% |
| Psychotic Disorder Due To A General Medical Condition |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Bronchitis |
2.9% |
| Coronary Artery Disease |
2.9% |
| Disseminated Tuberculosis |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Arrhythmia |
2.4% |
| Osteoarthritis |
2.4% |
| Angina Pectoris |
1.9% |
| Combined Immunodeficiency |
1.9% |
| Constipation |
1.9% |
|
| Drug Interaction |
29.2% |
| Renal Failure Acute |
10.8% |
| Duodenal Ulcer Haemorrhage |
6.2% |
| Vomiting |
6.2% |
| Blood Creatinine Increased |
4.6% |
| Tachyarrhythmia |
4.6% |
| Upper Gastrointestinal Haemorrhage |
4.6% |
| Asthenia |
3.1% |
| Foetal Damage |
3.1% |
| Gastric Ulcer Perforation |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Pain In Extremity |
3.1% |
| Spinal Epidural Haemorrhage |
3.1% |
| Therapeutic Agent Toxicity |
3.1% |
| Urticaria |
3.1% |
| Vision Blurred |
3.1% |
| Angina Pectoris |
1.5% |
| Anxiety |
1.5% |
| Cardiomegaly |
1.5% |
| Decreased Appetite |
1.5% |
|
